Research finds vaccine hesitancy among U.S. pet owners is rising

A 2024 study shows increasing vaccine hesitancy among U.S. pet owners, with many questioning vaccine effectiveness and the number of shots pets receive, researchers and a Texas A&M public health expert say.

A medium-sized mixed-breed dog sitting on a veterinary exam table under natural window light, looking alert.

Research published in 2024 finds vaccine hesitancy among pet owners in the United States is growing and is changing how people decide whether to vaccinate their dogs and cats.

The trend matters because vaccines protect companion animals and help prevent diseases that can spread among animals and, in some cases, between animals and people. Public health researchers and veterinary journals have documented the shift and are urging attention to its potential implications.

The 2024 findings were discussed by a public health researcher affiliated with Texas A&M, whose work was highlighted in public-facing communications and coverage, including a Texas A&M–related story and a Gavi/Conversation article. The research draws on surveys of pet owners and echoes conclusions from an earlier study published in 2023.

Survey results highlighted skepticism about vaccines. “More than half of pet owners question the effectiveness of vaccines,” the Public Health Expert at Texas A&M said. The researcher also noted a separate, related finding: “About 60% of pet owners thought that pets receive too many vaccines.”

Dogs (Canis lupus familiaris) and cats (Felis catus) — identified in the research as common pets that require vaccinations — figure centrally in the discussion. The study frames owners’ concerns as mirroring vaccine hesitancy patterns seen in human populations, and it underlines the role of routine immunizations in maintaining animal health.

The research appears alongside reporting and analysis in established journals. The American Journal of Veterinary Research and Vaccine are listed among the outlets that have published related findings, and the U.S. Department of Agriculture, particularly the USDA Center for Veterinary Biologics, is responsible for licensing and overseeing the safety, potency, and purity of most veterinary vaccines in the United States.

Researchers and communicators stressed two linked points: that owners’ questions about vaccine effectiveness are widespread, and that many owners worry pets receive too many vaccines. Those attitudes, the Public Health Expert at Texas A&M said, could reshape veterinary practice and client conversations about preventive care.

Earlier work published in 2023 tracked similar patterns, and the 2024 analysis builds on that earlier research to show a continuing trend. Commentary accompanying the new study places those survey results in the broader context of public perceptions about immunization and trust in medical recommendations.

Observers point to the practical consequences for animal health: vaccines provide important protections for nonhuman companions, and declining uptake could affect preventive care routines. At the same time, officials who oversee vaccine approvals continue to note safety standards. The U.S. Department of Agriculture’s role in approving vaccines for safety remains a central part of the regulatory backdrop to the conversation.

Public-facing summaries of the work appear in university communications and broader outlets. For a discussion of the research and its implications, see the Texas A&M Stories piece that featured the public health expert’s comments, and a related overview at Gavi that explores similar themes.

Source

Original reporting: view the original article.

Comments are closed.